4Filing Date: Jan 26, 2026

Gilead (GILD) 4: O'Day Daniel Patrick bought 115,640 shares of Common Stock… (Jan 26, 2026)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001638643-26-000004
Total Value$23.24M
Trades3
Insiders1

Transaction Details

O'Day Daniel Patrick
Chairman & CEO, Director·Direct
Sell · Dispose
Common Stock
Shares-115.64K
Price$135.00
Total Value$15.61M
Shares Owned After566.70K
Transaction DateJan 23, 2026
10b5-1
Footnotes ▸

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.

O'Day Daniel Patrick
Chairman & CEO, Director·Direct
Exercise · Dispose
Non-qualified Stock Option (Right to Buy)Derivative
Shares-115.64K
Price$0.00
Total Value$0
Shares Owned After115.64K
Transaction DateJan 23, 2026
ExpiresMar 1, 2029
10b5-1
Footnotes ▸

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. | The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

O'Day Daniel Patrick
Chairman & CEO, Director·Direct
Exercise · Acquire
Common Stock
Shares+115.64K
Price$66.01
Total Value$7.63M
Shares Owned After682.34K
Transaction DateJan 23, 2026
10b5-1
Footnotes ▸

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.

Post-Transaction Holdings

O'Day Daniel Patrick · Chairman & CEO, Director
SecuritySharesChange
Common Stock566.70K-
Non-qualified Stock Option (Right to Buy)115.64K-115.64K (-50.00%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-01-23 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: GILEAD SCIENCES, INC. (GILD) CIK: 0000882095 --- Reporting Owner --- Name: O'Day Daniel Patrick CIK: 0001638643 Role: Director, Officer (Chairman & CEO) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-01-23 | Code: M (Exercise of derivative) Shares: +115,640 | Price: $66.01 Total Value: $7,633,396.40 Shares Owned After: 682,338 | Ownership: D (Direct) Footnotes: [F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. [Transaction #2] Security: Common Stock Date: 2026-01-23 | Code: S (Open market sale) Shares: -115,640 | Price: $135.00 Total Value: $15,611,400.00 Shares Owned After: 566,698 | Ownership: D (Direct) Footnotes: [F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. --- Derivative Transactions --- [Transaction #1] Security: Non-qualified Stock Option (Right to Buy) Date: 2026-01-23 | Code: M (Exercise of derivative) Shares: -115,640 | Price: $0.00 Exercisable: N/A | Expires: 2029-03-01 Shares Owned After: 115,640 | Ownership: D (Direct) Footnotes: [F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. [F2] The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. --- Footnotes (Complete Index) --- F1: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. F2: The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. --- Signature --- /s/ /s/ Edward S. Son by Power of Attorney for Daniel P. O'Day (2026-01-26)

keid analysis is for reference only and does not constitute investment advice.